How many mg is in one benadryl

  • aclidinium

    diphenhydramine and aclidinium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • albuterol

    diphenhydramine increases and albuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • alfentanil

    diphenhydramine and alfentanil both increase sedation. Use Caution/Monitor.

  • alprazolam

    diphenhydramine and alprazolam both increase sedation. Use Caution/Monitor.

  • amantadine

    diphenhydramine, amantadine. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Potential for increased anticholinergic adverse effects.

  • amifampridine

    diphenhydramine increases toxicity of amifampridine by Other (see comment). Modify Therapy/Monitor Closely. Comment: Amifampridine can cause seizures. Coadministration with drugs that lower seizure threshold may increase this risk.

  • amitriptyline

    diphenhydramine and amitriptyline both decrease cholinergic effects/transmission. Modify Therapy/Monitor Closely.diphenhydramine and amitriptyline both increase sedation. Use Caution/Monitor.

  • amobarbital

    diphenhydramine and amobarbital both increase sedation. Use Caution/Monitor.

  • amoxapine

    diphenhydramine and amoxapine both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and amoxapine both increase sedation. Use Caution/Monitor.

  • anticholinergic/sedative combos

    anticholinergic/sedative combos and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • apomorphine

    diphenhydramine and apomorphine both increase sedation. Use Caution/Monitor.

  • arformoterol

    diphenhydramine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • aripiprazole

    diphenhydramine and aripiprazole both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of aripiprazole by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of aripiprazole by pharmacodynamic antagonism. Use Caution/Monitor.aripiprazole increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • armodafinil

    diphenhydramine increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • atomoxetine

    diphenhydramine will increase the level or effect of atomoxetine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • atracurium

    atracurium and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • atropine

    atropine and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • atropine IV/IM

    atropine IV/IM and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • azelastine

    azelastine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • baclofen

    diphenhydramine and baclofen both increase sedation. Use Caution/Monitor.

  • belladonna alkaloids

    belladonna alkaloids and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • belladonna and opium

    diphenhydramine and belladonna and opium both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and belladonna and opium both increase sedation. Use Caution/Monitor.

  • benperidol

    diphenhydramine and benperidol both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of benperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of benperidol by pharmacodynamic antagonism. Use Caution/Monitor.benperidol increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • benzhydrocodone/acetaminophen

    diphenhydramine will increase the level or effect of benzhydrocodone/acetaminophen by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Hydromorphone (<3% of the circulating parent hydrocodone [benzhydrocodone is prodrug of hydrocodone]) is mainly formed by CYP2D6 mediated O-demethylation of hydrocodone. Hydromorphone may contribute to the total analgesic effect of hydrocodone.

  • benzphetamine

    diphenhydramine increases and benzphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • benztropine

    benztropine and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor. Additive anticholinergic adverse effects may be seen with concurrent use.

  • bethanechol

    bethanechol increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • brexanolone

    brexanolone, diphenhydramine. Either increases toxicity of the other by sedation. Use Caution/Monitor.

  • brexpiprazole

    diphenhydramine will increase the level or effect of brexpiprazole by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Administer a quarter of brexpiprazole dose if coadministered with a moderate CYP2D6 inhibitor PLUS a strong/moderate CYP3A4 inhibitor.

  • brompheniramine

    brompheniramine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • buprenorphine

    diphenhydramine and buprenorphine both increase sedation. Use Caution/Monitor.

  • buprenorphine buccal

    diphenhydramine and buprenorphine buccal both increase sedation. Use Caution/Monitor.

  • butabarbital

    diphenhydramine and butabarbital both increase sedation. Use Caution/Monitor.

  • butalbital

    diphenhydramine and butalbital both increase sedation. Use Caution/Monitor.

  • butorphanol

    diphenhydramine and butorphanol both increase sedation. Use Caution/Monitor.

  • caffeine

    diphenhydramine increases and caffeine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • carbachol

    carbachol increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • carbinoxamine

    carbinoxamine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • carisoprodol

    diphenhydramine and carisoprodol both increase sedation. Use Caution/Monitor.

  • carvedilol

    diphenhydramine will increase the level or effect of carvedilol by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • cenobamate

    cenobamate, diphenhydramine. Either increases effects of the other by sedation. Use Caution/Monitor.

  • cevimeline

    cevimeline increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • chloral hydrate

    diphenhydramine and chloral hydrate both increase sedation. Use Caution/Monitor.

  • chlordiazepoxide

    diphenhydramine and chlordiazepoxide both increase sedation. Use Caution/Monitor.

  • chlorpheniramine

    chlorpheniramine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • chlorpromazine

    diphenhydramine and chlorpromazine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of chlorpromazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of chlorpromazine by pharmacodynamic antagonism. Use Caution/Monitor.chlorpromazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • chlorzoxazone

    diphenhydramine and chlorzoxazone both increase sedation. Use Caution/Monitor.

  • cinnarizine

    cinnarizine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • cisatracurium

    cisatracurium and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • clemastine

    clemastine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • clobazam

    diphenhydramine, clobazam. Other (see comment). Use Caution/Monitor. Comment: Concomitant administration can increase the potential for CNS effects (e.g., increased sedation or respiratory depression).

  • clomipramine

    diphenhydramine will increase the level or effect of clomipramine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and clomipramine both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and clomipramine both increase sedation. Use Caution/Monitor.

  • clonazepam

    diphenhydramine and clonazepam both increase sedation. Use Caution/Monitor.

  • clorazepate

    diphenhydramine and clorazepate both increase sedation. Use Caution/Monitor.

  • clozapine

    diphenhydramine and clozapine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of clozapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of clozapine by pharmacodynamic antagonism. Use Caution/Monitor.clozapine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • codeine

    diphenhydramine decreases effects of codeine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Prevents conversion of codeine to its active metabolite morphine.diphenhydramine and codeine both increase sedation. Use Caution/Monitor.

  • cyclizine

    cyclizine and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.cyclizine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • cyclobenzaprine

    cyclobenzaprine and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and cyclobenzaprine both increase sedation. Use Caution/Monitor.

  • cyproheptadine

    cyproheptadine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • dantrolene

    diphenhydramine and dantrolene both increase sedation. Use Caution/Monitor.

  • daridorexant

    diphenhydramine and daridorexant both increase sedation. Modify Therapy/Monitor Closely. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment.

  • darifenacin

    darifenacin and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • desflurane

    desflurane and diphenhydramine both increase sedation. Use Caution/Monitor.

  • desipramine

    diphenhydramine will increase the level or effect of desipramine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and desipramine both increase sedation. Use Caution/Monitor.

  • deutetrabenazine

    diphenhydramine and deutetrabenazine both increase sedation. Use Caution/Monitor.

  • dexchlorpheniramine

    dexchlorpheniramine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • dexfenfluramine

    diphenhydramine increases and dexfenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dexmedetomidine

    diphenhydramine and dexmedetomidine both increase sedation. Use Caution/Monitor.

  • dexmethylphenidate

    diphenhydramine increases and dexmethylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dextroamphetamine

    diphenhydramine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dextromoramide

    diphenhydramine and dextromoramide both increase sedation. Use Caution/Monitor.

  • diamorphine

    diphenhydramine and diamorphine both increase sedation. Use Caution/Monitor.

  • diazepam

    diphenhydramine and diazepam both increase sedation. Use Caution/Monitor.

  • diazepam intranasal

    diazepam intranasal, diphenhydramine. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Coadministration may potentiate the CNS-depressant effects of each drug.

  • dicyclomine

    dicyclomine and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • diethylpropion

    diphenhydramine increases and diethylpropion decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • difelikefalin

    difelikefalin and diphenhydramine both increase sedation. Use Caution/Monitor.

  • difenoxin hcl

    diphenhydramine and difenoxin hcl both increase sedation. Use Caution/Monitor.

  • dimenhydrinate

    dimenhydrinate and diphenhydramine both increase sedation. Use Caution/Monitor.

  • diphenoxylate hcl

    diphenhydramine and diphenoxylate hcl both increase sedation. Use Caution/Monitor.

  • dipipanone

    diphenhydramine and dipipanone both increase sedation. Use Caution/Monitor.

  • dobutamine

    diphenhydramine increases and dobutamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • donepezil

    donepezil increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • donepezil transdermal

    donepezil transdermal, diphenhydramine. Either decreases effects of the other by pharmacodynamic antagonism. Use Caution/Monitor.

  • dopamine

    diphenhydramine increases and dopamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dopexamine

    diphenhydramine increases and dopexamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dosulepin

    diphenhydramine and dosulepin both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and dosulepin both increase sedation. Use Caution/Monitor.

  • doxepin

    diphenhydramine and doxepin both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and doxepin both increase sedation. Use Caution/Monitor.

  • doxylamine

    diphenhydramine and doxylamine both increase sedation. Use Caution/Monitor.

  • droperidol

    diphenhydramine and droperidol both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of droperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of droperidol by pharmacodynamic antagonism. Use Caution/Monitor.droperidol increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • duloxetine

    diphenhydramine will increase the level or effect of duloxetine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • echothiophate iodide

    echothiophate iodide increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • ephedrine

    diphenhydramine increases and ephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • epinephrine

    diphenhydramine increases and epinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • epinephrine racemic

    diphenhydramine increases and epinephrine racemic decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • esketamine intranasal

    esketamine intranasal, diphenhydramine. Either increases toxicity of the other by sedation. Modify Therapy/Monitor Closely.

  • estazolam

    diphenhydramine and estazolam both increase sedation. Use Caution/Monitor.

  • ethanol

    diphenhydramine and ethanol both increase sedation. Use Caution/Monitor.

  • etomidate

    etomidate and diphenhydramine both increase sedation. Use Caution/Monitor.

  • fenfluramine

    diphenhydramine increases and fenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • fentanyl

    fentanyl, diphenhydramine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • fentanyl intranasal

    fentanyl intranasal, diphenhydramine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • fentanyl transdermal

    fentanyl transdermal, diphenhydramine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • fentanyl transmucosal

    fentanyl transmucosal, diphenhydramine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • fesoterodine

    diphenhydramine and fesoterodine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • flavoxate

    diphenhydramine and flavoxate both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • flecainide

    diphenhydramine will increase the level or effect of flecainide by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • flibanserin

    diphenhydramine and flibanserin both increase sedation. Modify Therapy/Monitor Closely. Risk for sedation increased if flibanserin is coadministration with other CNS depressants.

  • fluphenazine

    diphenhydramine and fluphenazine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of fluphenazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of fluphenazine by pharmacodynamic antagonism. Use Caution/Monitor.fluphenazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • flurazepam

    diphenhydramine and flurazepam both increase sedation. Use Caution/Monitor.

  • formoterol

    diphenhydramine increases and formoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • gabapentin

    gabapentin, diphenhydramine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.

  • gabapentin enacarbil

    gabapentin enacarbil, diphenhydramine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.

  • galantamine

    galantamine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • ganaxolone

    diphenhydramine and ganaxolone both increase sedation. Use Caution/Monitor.

  • glycopyrrolate

    diphenhydramine and glycopyrrolate both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • glycopyrrolate inhaled

    diphenhydramine and glycopyrrolate inhaled both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • glycopyrronium tosylate topical

    glycopyrronium tosylate topical, diphenhydramine. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Coadministration of glycopyrronium tosylate topical with other anticholinergic medications may result in additive anticholinergic adverse effects.

  • gotu kola

    gotu kola increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • haloperidol

    diphenhydramine will increase the level or effect of haloperidol by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and haloperidol both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of haloperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of haloperidol by pharmacodynamic antagonism. Use Caution/Monitor.haloperidol increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • hawthorn

    hawthorn increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • henbane

    diphenhydramine and henbane both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • homatropine

    diphenhydramine and homatropine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • hops

    hops increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • huperzine A

    huperzine A increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • hyaluronidase

    diphenhydramine decreases effects of hyaluronidase by Other (see comment). Use Caution/Monitor. Comment: Antihistamines, when given in large systemic doses, may render tissues partially resistant to the action of hyaluronidase. Patients may require larger amounts of hyaluronidase for equivalent dispersing effect.

  • hydrocodone

    diphenhydramine will increase the level or effect of hydrocodone by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Hydromorphone (<3% of the circulating parent hydrocodone) is mainly formed by CYP2D6 mediated O-demethylation of hydrocodone. Hydromorphone may contribute to the total analgesic effect of hydrocodone.

  • hydromorphone

    diphenhydramine will increase the level or effect of hydromorphone by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and hydromorphone both increase sedation. Use Caution/Monitor.

  • hydroxyzine

    diphenhydramine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • hyoscyamine

    diphenhydramine and hyoscyamine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • hyoscyamine spray

    diphenhydramine and hyoscyamine spray both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • iloperidone

    diphenhydramine will increase the level or effect of iloperidone by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and iloperidone both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of iloperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of iloperidone by pharmacodynamic antagonism. Use Caution/Monitor.iloperidone increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • imipramine

    diphenhydramine will increase the level or effect of imipramine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and imipramine both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and imipramine both increase sedation. Use Caution/Monitor.

  • ipratropium

    diphenhydramine and ipratropium both decrease cholinergic effects/transmission. Use Caution/Monitor. Due to the poor systemic absorption of ipratropium, interaction unlikely at regularly recommended dosages.

  • isoproterenol

    diphenhydramine increases and isoproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • kava

    kava increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • ketamine

    ketamine and diphenhydramine both increase sedation. Use Caution/Monitor.

  • ketotifen, ophthalmic

    diphenhydramine and ketotifen, ophthalmic both increase sedation. Use Caution/Monitor.

  • lasmiditan

    lasmiditan, diphenhydramine. Either increases effects of the other by sedation. Use Caution/Monitor. Coadministration of lasmiditan and other CNS depressant drugs, including alcohol have not been evaluated in clinical studies. Lasmiditan may cause sedation, as well as other cognitive and/or neuropsychiatric adverse reactions.

  • lemborexant

    lemborexant, diphenhydramine. Either increases effects of the other by sedation. Modify Therapy/Monitor Closely. Dosage adjustment may be necessary if lemborexant is coadministered with other CNS depressants because of potentially additive effects.

  • levalbuterol

    diphenhydramine increases and levalbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • levodopa

    diphenhydramine, levodopa. Other (see comment). Use Caution/Monitor. Comment: Anticholinergic agents may enhance the therapeutic effects of levodopa; however, anticholinergic agents can exacerbate tardive dyskinesia. In high dosage, anticholinergics may decrease the effects of levodopa by delaying its GI absorption. .

  • levorphanol

    diphenhydramine and levorphanol both increase sedation. Use Caution/Monitor.

  • lisdexamfetamine

    diphenhydramine increases and lisdexamfetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • lofepramine

    diphenhydramine will increase the level or effect of lofepramine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and lofepramine both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and lofepramine both increase sedation. Use Caution/Monitor.

  • lofexidine

    diphenhydramine and lofexidine both increase sedation. Use Caution/Monitor.

  • loprazolam

    diphenhydramine and loprazolam both increase sedation. Use Caution/Monitor.

  • lorazepam

    diphenhydramine and lorazepam both increase sedation. Use Caution/Monitor.

  • lormetazepam

    diphenhydramine and lormetazepam both increase sedation. Use Caution/Monitor.

  • loxapine

    diphenhydramine and loxapine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of loxapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of loxapine by pharmacodynamic antagonism. Use Caution/Monitor.loxapine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • loxapine inhaled

    loxapine inhaled increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.diphenhydramine and loxapine inhaled both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of loxapine inhaled by pharmacodynamic antagonism. Use Caution/Monitor.

  • lurasidone

    lurasidone, diphenhydramine. Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. Comment: Potential for increased CNS depressant effects when used concurrently; monitor for increased adverse effects and toxicity.

  • maprotiline

    diphenhydramine and maprotiline both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and maprotiline both increase sedation. Use Caution/Monitor.

  • marijuana

    diphenhydramine and marijuana both increase sedation. Use Caution/Monitor.

  • meclizine

    diphenhydramine and meclizine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • melatonin

    diphenhydramine and melatonin both increase sedation. Use Caution/Monitor.

  • meperidine

    diphenhydramine and meperidine both increase sedation. Use Caution/Monitor.

  • meprobamate

    diphenhydramine and meprobamate both increase sedation. Use Caution/Monitor.

  • metaproterenol

    diphenhydramine increases and metaproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • metaxalone

    diphenhydramine and metaxalone both increase sedation. Use Caution/Monitor.

  • methadone

    diphenhydramine and methadone both increase sedation. Use Caution/Monitor.

  • methamphetamine

    diphenhydramine will increase the level or effect of methamphetamine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • methocarbamol

    diphenhydramine and methocarbamol both increase sedation. Use Caution/Monitor.

  • methscopolamine

    diphenhydramine and methscopolamine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • methylenedioxymethamphetamine

    diphenhydramine increases and methylenedioxymethamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • metoprolol

    diphenhydramine will increase the level or effect of metoprolol by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • mexiletine

    diphenhydramine will increase the level or effect of mexiletine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • midazolam

    diphenhydramine and midazolam both increase sedation. Use Caution/Monitor.

  • midazolam intranasal

    midazolam intranasal, diphenhydramine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Concomitant use of barbiturates, alcohol, or other CNS depressants may increase risk of hypoventilation, airway obstruction, desaturation, or apnea and may contribute to profound and/or prolonged drug effect.

  • midodrine

    diphenhydramine increases and midodrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • mirtazapine

    diphenhydramine and mirtazapine both increase sedation. Use Caution/Monitor.

  • modafinil

    diphenhydramine increases and modafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • morphine

    diphenhydramine will increase the level or effect of morphine by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and morphine both increase sedation. Use Caution/Monitor.

  • motherwort

    diphenhydramine and motherwort both increase sedation. Use Caution/Monitor.

  • moxonidine

    diphenhydramine and moxonidine both increase sedation. Use Caution/Monitor.

  • nabilone

    diphenhydramine and nabilone both increase sedation. Use Caution/Monitor.

  • nalbuphine

    diphenhydramine and nalbuphine both increase sedation. Use Caution/Monitor.

  • nebivolol

    diphenhydramine will increase the level or effect of nebivolol by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • neostigmine

    neostigmine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • norepinephrine

    diphenhydramine increases and norepinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • nortriptyline

    diphenhydramine will increase the level or effect of nortriptyline by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and nortriptyline both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and nortriptyline both increase sedation. Use Caution/Monitor.

  • olanzapine

    diphenhydramine and olanzapine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of olanzapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of olanzapine by pharmacodynamic antagonism. Use Caution/Monitor.olanzapine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • oliceridine

    diphenhydramine will increase the level or effect of oliceridine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. If concomitant use is necessary, may require less frequent oliceridine dosing. Closely monitor for respiratory depression and sedation and titrate subsequent doses accordingly. If inhibitor is discontinued, consider increase oliceridine dosage until stable drug effects are achieved. Monitor for signs of opioid withdrawal.

  • onabotulinumtoxinA

    onabotulinumtoxinA and diphenhydramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • opium tincture

    diphenhydramine and opium tincture both increase sedation. Use Caution/Monitor.

  • orphenadrine

    diphenhydramine and orphenadrine both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and orphenadrine both increase sedation. Use Caution/Monitor.

  • ospemifene

    diphenhydramine, ospemifene. Either increases levels of the other by plasma protein binding competition. Modify Therapy/Monitor Closely.

  • oxazepam

    diphenhydramine and oxazepam both increase sedation. Use Caution/Monitor.

  • oxybutynin

    diphenhydramine and oxybutynin both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • oxybutynin topical

    diphenhydramine and oxybutynin topical both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • oxybutynin transdermal

    diphenhydramine and oxybutynin transdermal both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • oxycodone

    diphenhydramine will increase the level or effect of oxycodone by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and oxycodone both increase sedation. Use Caution/Monitor.

  • oxymorphone

    diphenhydramine will increase the level or effect of oxymorphone by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.diphenhydramine and oxymorphone both increase sedation. Use Caution/Monitor.

  • paliperidone

    diphenhydramine and paliperidone both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of paliperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of paliperidone by pharmacodynamic antagonism. Use Caution/Monitor.paliperidone increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • pancuronium

    diphenhydramine and pancuronium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • papaveretum

    diphenhydramine and papaveretum both increase sedation. Use Caution/Monitor.

  • papaverine

    diphenhydramine and papaverine both increase sedation. Use Caution/Monitor.

  • passion flower

    passion flower increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • pentazocine

    diphenhydramine and pentazocine both increase sedation. Use Caution/Monitor.

  • pentobarbital

    diphenhydramine and pentobarbital both increase sedation. Use Caution/Monitor.

  • perampanel

    perampanel and diphenhydramine both increase sedation. Use Caution/Monitor.

  • perphenazine

    diphenhydramine and perphenazine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of perphenazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of perphenazine by pharmacodynamic antagonism. Use Caution/Monitor.perphenazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • phendimetrazine

    diphenhydramine increases and phendimetrazine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • phenelzine

    phenelzine increases effects of diphenhydramine by Other (see comment). Modify Therapy/Monitor Closely. Comment: Coadministration of phenelzine and antihistamines may result in additive CNS depressant effects. MAO inhibitors also prolong and intensify anticholinergic effects of antihistamines. .

  • phenobarbital

    diphenhydramine and phenobarbital both increase sedation. Use Caution/Monitor.

  • phentermine

    diphenhydramine increases and phentermine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • phenylephrine

    diphenhydramine increases and phenylephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • phenylephrine PO

    diphenhydramine increases and phenylephrine PO decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor. .

  • pholcodine

    diphenhydramine and pholcodine both increase sedation. Use Caution/Monitor.

  • physostigmine

    physostigmine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • pilocarpine

    pilocarpine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • pimozide

    diphenhydramine and pimozide both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of pimozide by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of pimozide by pharmacodynamic antagonism. Use Caution/Monitor.pimozide increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • pirbuterol

    diphenhydramine increases and pirbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • pralidoxime

    diphenhydramine and pralidoxime both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • pregabalin

    pregabalin, diphenhydramine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.

  • primidone

    diphenhydramine and primidone both increase sedation. Use Caution/Monitor.

  • prochlorperazine

    diphenhydramine and prochlorperazine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of prochlorperazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of prochlorperazine by pharmacodynamic antagonism. Use Caution/Monitor.prochlorperazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • promethazine

    diphenhydramine and promethazine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of promethazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of promethazine by pharmacodynamic antagonism. Use Caution/Monitor.promethazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • propafenone

    diphenhydramine will increase the level or effect of propafenone by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • propantheline

    diphenhydramine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • propofol

    propofol and diphenhydramine both increase sedation. Use Caution/Monitor.

  • propranolol

    diphenhydramine will increase the level or effect of propranolol by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • propylhexedrine

    diphenhydramine increases and propylhexedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • protriptyline

    diphenhydramine and protriptyline both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and protriptyline both increase sedation. Use Caution/Monitor.

  • pyridostigmine

    pyridostigmine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • quazepam

    diphenhydramine and quazepam both increase sedation. Use Caution/Monitor.

  • quetiapine

    diphenhydramine and quetiapine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of quetiapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of quetiapine by pharmacodynamic antagonism. Use Caution/Monitor.quetiapine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • ramelteon

    diphenhydramine and ramelteon both increase sedation. Use Caution/Monitor.

  • rapacuronium

    diphenhydramine and rapacuronium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • risperidone

    diphenhydramine and risperidone both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of risperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of risperidone by pharmacodynamic antagonism. Use Caution/Monitor.risperidone increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • rocuronium

    diphenhydramine and rocuronium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • salmeterol

    diphenhydramine increases and salmeterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • scopolamine

    diphenhydramine and scopolamine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • scullcap

    diphenhydramine and scullcap both increase sedation. Use Caution/Monitor.

  • secobarbital

    diphenhydramine and secobarbital both increase sedation. Use Caution/Monitor.

  • sevoflurane

    sevoflurane and diphenhydramine both increase sedation. Use Caution/Monitor.

  • shepherd's purse

    diphenhydramine and shepherd's purse both increase sedation. Use Caution/Monitor.

  • solifenacin

    diphenhydramine and solifenacin both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • stiripentol

    stiripentol, diphenhydramine. Either increases effects of the other by sedation. Use Caution/Monitor. Concomitant use stiripentol with other CNS depressants, including alcohol, may increase the risk of sedation and somnolence.

  • succinylcholine

    succinylcholine increases and diphenhydramine decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • sufentanil

    diphenhydramine and sufentanil both increase sedation. Use Caution/Monitor.

  • tamoxifen

    diphenhydramine decreases effects of tamoxifen by decreasing metabolism. Use Caution/Monitor. Inhibition of CYP2D6 metabolism to tamoxifen's active metabolite, endoxifen.

  • tamsulosin

    diphenhydramine increases levels of tamsulosin by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • tapentadol

    diphenhydramine and tapentadol both increase sedation. Use Caution/Monitor.

  • temazepam

    diphenhydramine and temazepam both increase sedation. Use Caution/Monitor.

  • terbutaline

    diphenhydramine increases and terbutaline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • thioridazine

    diphenhydramine and thioridazine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of thioridazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of thioridazine by pharmacodynamic antagonism. Use Caution/Monitor.thioridazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • thiothixene

    diphenhydramine and thiothixene both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of thiothixene by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of thiothixene by pharmacodynamic antagonism. Use Caution/Monitor.thiothixene increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • timolol

    diphenhydramine will increase the level or effect of timolol by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor.

  • tiotropium

    diphenhydramine and tiotropium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • tolterodine

    diphenhydramine and tolterodine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • topiramate

    diphenhydramine and topiramate both increase sedation. Modify Therapy/Monitor Closely.

  • tramadol

    diphenhydramine decreases effects of tramadol by affecting hepatic enzyme CYP2D6 metabolism. Use Caution/Monitor. Decreased conversion of tramadol to active metabolite.diphenhydramine and tramadol both increase sedation. Use Caution/Monitor.diphenhydramine decreases effects of tramadol by decreasing metabolism. Use Caution/Monitor. Decreased conversion of tramadol to active metabolite.

  • trazodone

    diphenhydramine and trazodone both increase sedation. Use Caution/Monitor.

  • triazolam

    diphenhydramine and triazolam both increase sedation. Use Caution/Monitor.

  • triclofos

    diphenhydramine and triclofos both increase sedation. Use Caution/Monitor.

  • trifluoperazine

    diphenhydramine and trifluoperazine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of trifluoperazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of trifluoperazine by pharmacodynamic antagonism. Use Caution/Monitor.trifluoperazine increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • trihexyphenidyl

    diphenhydramine and trihexyphenidyl both decrease cholinergic effects/transmission. Use Caution/Monitor. Potential for additive anticholinergic effects.

  • trimipramine

    diphenhydramine and trimipramine both decrease cholinergic effects/transmission. Use Caution/Monitor.diphenhydramine and trimipramine both increase sedation. Use Caution/Monitor.

  • triprolidine

    diphenhydramine and triprolidine both increase sedation. Use Caution/Monitor.

  • trospium chloride

    diphenhydramine and trospium chloride both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • valerian

    valerian increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • vecuronium

    diphenhydramine and vecuronium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • xylometazoline

    diphenhydramine increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • yohimbine

    diphenhydramine increases and yohimbine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • ziconotide

    diphenhydramine and ziconotide both increase sedation. Use Caution/Monitor.

  • ziprasidone

    diphenhydramine and ziprasidone both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of ziprasidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of ziprasidone by pharmacodynamic antagonism. Use Caution/Monitor.ziprasidone increases effects of diphenhydramine by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • zotepine

    diphenhydramine and zotepine both increase sedation. Use Caution/Monitor.diphenhydramine decreases levels of zotepine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.diphenhydramine decreases levels of zotepine by pharmacodynamic antagonism. Use Caution/Monitor.

  • How many Benadryl 50 mg can I take?

    Do not take more than 6 doses in 24 hours. Use only as directed. 2 to 4 chewable tablets (25 mg to 50 mg) every 4 to 6 hours or as directed by a doctor.

    How many 10 mg Benadryl can I take?

    Adults and adolescents over 12 years of age: 10 mg once daily (1 tablet). The tablets need to be swallowed with a glass of liquid.

    Can I take 3 Benadryl at once?

    Although online challenges may encourage it, it is not safe to take more than the recommended dosage of Benadryl. Doing so can lead to overdose and severe symptoms, including abnormal heart rhythms, hallucinations, seizures, and even death in rare cases.

    How many 25mg Benadryl can I take at once?

    Use Adult BENADRYL® products. 1 to 2 tablets every 4 to 6 hours. Do not exceed 8 tablets in 24 hours.